Torii Pharmaceutical Co., Ltd. (4551) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Sumitomo Pharma Co., Ltd.

Towa Pharmaceutical Co., Ltd.

Mochida Pharmaceutical Co., Ltd.

Tsumura & Co.

Zeria Pharmaceutical Co., Ltd.

JCR Pharmaceuticals Co., Ltd.

KYORIN Pharmaceutical Co., Ltd.

Torii Pharmaceutical Co., Ltd.

SAWAI GROUP HOLDINGS Co., Ltd.

Kaken Pharmaceutical Co., Ltd.

Nxera Pharma Co., Ltd.

Why is Torii Pharmaceutical Co., Ltd. ?

Negative results in Jun 25

DIVIDEND PAYOUT RATIO(Y) Lowest at 0%
CASH AND EQV(HY) Lowest at JPY 74,564 MM
DEBT-EQUITY RATIO (HY) Highest at -27.19 %

With ROE of 4.58%, it has a very attractive valuation with a 1.50 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 78.87%, its profits have risen by 5.1% ; the PEG ratio of the company is 6.4
At the current price, the company has a high dividend yield of 0

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Torii Pharmaceutical Co., Ltd. for you?

Medium Risk, High Return

Absolute

Risk Adjusted

Volatility

Torii Pharmaceutical Co., Ltd.

78.87%

689.34

35.46%

Japan Nikkei 225

28.54%

0.82

24.83%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

7.27%

EBIT Growth (5y)

15.98%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.34

Sales to Capital Employed (avg)

0.47

Tax Ratio

25.11%

Dividend Payout Ratio

66.90%

Pledged Shares

Institutional Holding

ROCE (avg)

8.52%

ROE (avg)

3.61%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.50

EV to EBIT

19.89

EV to EBITDA

18.83

EV to Capital Employed

1.76

EV to Sales

2.30

PEG Ratio

6.42

Dividend Yield

0.02%

ROCE (Latest)

8.85%

ROE (Latest)

4.58%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

Bearish

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

Bullish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

ROCE(HY)

Highest at 4.45%

-10What is not working for the Company

DIVIDEND PAYOUT RATIO(Y)

Lowest at 0%

CASH AND EQV(HY)

Lowest at JPY 74,564 MM

DEBT-EQUITY RATIO (HY)

Highest at -27.19 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.44%

DIVIDEND PER SHARE(HY)

Lowest at JPY 2.28

OPERATING PROFIT(Q)

Lowest at JPY 1,548 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 9.27 %

PRE-TAX PROFIT(Q)

Lowest at JPY 1,608 MM

NET PROFIT(Q)

Lowest at JPY 1,197 MM

EPS(Q)

Lowest at JPY 42.58

Here's what is not working for Torii Pharmaceutical Co., Ltd.

Operating Profit

Lowest at JPY 1,548 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (JPY MM)

Operating Profit Margin

Lowest at 9.27 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at JPY 1,608 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (JPY MM)

Net Profit

Lowest at JPY 1,197 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (JPY MM)

EPS

Lowest at JPY 42.58

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (JPY)

Cash and Eqv

Lowest at JPY 74,564 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at -27.19 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 2.44%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Dividend per share

Lowest at JPY 2.28

in the last five years

MOJO Watch

Company is distributing lower dividend than previous years

DPS (JPY)

Dividend Payout Ratio

Lowest at 0%

in the last five years

MOJO Watch

Company is distributing lower proportion of profits generated as dividend

DPR (%)